Phase 1b clinical trial investigating Satoreotide tetraxetan
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Satoreotide tetraxetan (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 16 Jan 2025 New trial record